ijms-logo

Journal Browser

Journal Browser

Recent Advances in New Biomarkers for Cancers

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Oncology".

Deadline for manuscript submissions: 30 September 2025 | Viewed by 102

Special Issue Editor


E-Mail Website
Guest Editor
Laboratory of Pharmacology, Department of Medicine, Democritus University of Thrace, 68100 Alexandroupolis, Greece
Interests: biomarkers in cancer and other diseases; liquid biopsy; epigenetics; machine learning; data-driven biomarker discovery; cancer research

Special Issue Information

Dear Colleagues,

Cancer is one of the leading causes of death worldwide, with approximately 20 million new cases in 2022, indicating the critical need for the identification of innovative tools to enhance early diagnosis, accurate prognosis, and treatment monitoring. Therefore, the identification and validation of new, reliable, and specific biomarkers in tissue or liquid biopsy for cancer management are of great importance in oncology research.

This Special Issue on “Recent Advances in New Biomarkers for Cancers” aims to explore recent advances, translational research, and emerging technologies in biomarker research for improving early detection, personalized treatment options, and therapeutic monitoring.

Since IJMS is a journal of molecular science, pure clinical studies will not be suitable for our journal. However, clinical or pure model submissions with biomolecular experiments are welcomed.

This Special Issue invites original research articles, reviews, and perspectives on topics including but not limited to the following:

  • Identification and validation of novel biomarkers in various cancer types in tissue and liquid biopsy;
  • Genetic, epigenetic, transcriptomic, proteomic, and metabolomic biomarkers;
  • Latest advancements in analytical methods’ implementation and standardization for biomarker detection;
  • Role of biomarkers in early cancer detection, minimal residual disease (MRD) assessment, prognosis, treatment response prediction, and monitoring;
  • Application of multi-omics data for biomarker discovery for precision oncology;
  • Emerging trends in data-driven and machine learning biomarker discovery.

This Special Issue aims to highlight cutting-edge research in the rapidly evolving field of cancer biomarkers.

Dr. Maria Panagopoulou
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • biomarkers
  • cancer research
  • liquid biopsy
  • epigenetic and genetic biomarkers
  • precision oncology
  • diagnosis
  • prognosis
  • prediction

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop